Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Shaare Zedek Medical Center |
---|---|
Information provided by: | Shaare Zedek Medical Center |
ClinicalTrials.gov Identifier: | NCT00394797 |
The purpose of this study is to try and determine whether repair of moderate ischemic mitral regurgitation at the time of coronary bypass graft surgery (CABG) has an impact on survival.Patients will be randomized to CABG + mitral repair or CABG only groups. Primary endpoints include late survival.
Secondary endpoints include event free survival, symptoms, and echocardiographic outcomes.
Condition | Intervention |
---|---|
Moderate Ischemic Mitral Regurgitation |
Procedure: mitral valve annuloplasty |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Active Control, Parallel Assignment |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | IMR001 |
Study First Received: | October 31, 2006 |
Last Updated: | October 31, 2006 |
ClinicalTrials.gov Identifier: | NCT00394797 History of Changes |
Health Authority: | Israel: Ministry of Health |
Heart Diseases Ischemia Heart Valve Diseases Mitral Valve Insufficiency |
Heart Diseases Cardiovascular Diseases Heart Valve Diseases Mitral Valve Insufficiency |